The research department at Dayton Center for Neurological Disorders was started in 2013. Since then, we have been actively involved in several prominent research studies related to Multiple Sclerosis, Parkinson’s Disease, and Alzheimer’s Disease. Call 937-424-3033 for more information.
It’s all about getting answers. DCND is committed to furthering science and medicine and helping patients. Getting involved in research can help the medical community develop new drugs and treatments that improve the quality of life for patients. The overall goal is to know as much as we can about a disease so we can better treat it.
By getting involved in research, you can help others in the same situation and possibly get access to cutting edge treatment not available for everyone yet.
What we are currently looking for:
- Diagnosed with multiple sclerosis
- Newly prescribed Gilenya
- Willing to have dermatology exams
- Never treated with Tysabri
- Diagnosed with relapsing, remitting MS
- Aged 18-60
- Treated with Tysabri for at least 11 months
- No relapses in prior 12 months
- Have advancing MS
- Age 18-65
- Willing to start Siponimod
- Diagnosed with MS
- Aged 18-70
- Experience walking impairment
- Have a diagnosis of Multiple Sclerosis
- Newly prescribed Tecfidera
- Never treated with Tecfidera previously
Interested in learning more about these studies? Call our research department at 937-424-3033
- Looking for 65-75 year olds who do not have a memory impairment, but are at risk related to family history. Call us for more information.
- More information at: www.generationprogram.com
Looking at clinical, economic, and humanistic impact of anti-psychotic therapy in the management of Parkinson’s disease psychosis.
- Diagnosed with Parkinson’s disease
- Experience symptoms of illusions, a false sense of presence, hallucinations, and/or delusions
- Have a caregiver willing to also participate
- Diagnosed with Parkinson’s Disease, multi-symptom atrophy
- Experience orthostatic hypo-tension
- Willing to take Northera
A study for Parkinson’s patients, aged 30-80 years old who experience:
- Mood disorders
- Changes in memory or thinking
- Sleep difficulties
- Urinary, weight and sexual problems
- Loss of sense of smell
- Impulsive control disorders such as binge eating and excessive shopping or gambling.
- Diagnosed with Parkinson’s
- Age 30-90
- Have constipation lasting greater than 6 months.
Registry to determine frequency and risk factors for ALS